ConcertAI
Highly Engaged Employees
Healthcare Software · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1120 Massachusetts Ave, Cambridge, Massa...Website
www.concertai.comRevenue
$200 MillionIndustry
About ConcertAI
ConcertAI Org Chart
Is ConcertAI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when ConcertAI launches new products
Check out if ConcertAI is spiking on competitors!
Check if ConcertAI has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ConcertAI has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at ConcertAI
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on ConcertAI recently announced quarterly report
Click to see if ConcertAI had a recent Job posting/layoffs
ConcertAI, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to ConcertAI
Compare insights from companies similar to ConcertAI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ConcertAI is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
ConcertAI is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about ConcertAI.
ConcertAI financials insights
Gather financial insights about ConcertAI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$150M
Series C
$150M
ConcertAI Tech Stack
A closer look at the technologies used by ConcertAI
Most Recent Scoops
ConcertAI News & Media
ConcertAI Appoints Michael Myshrall as Chief Financial Officer - Yahoo Finance
CAMBRIDGE, Mass., August 18, 2025--ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and life sciences, today announced the appointment of Michael Myshrall as chief financial officer (CFO). Myshrall brings over two decades of financial leadership experience in SaaS, artificial intelligence (AI) and technology sectors, positioning him to help accelerate ConcertAI's continued expansion and innovation in AI-powered clinical research aConcertAI Announces Leadership Transition to Accelerate AI Innovation and Growth
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data solutions for healthcare and life sciences, announced today that Eron Kelly has been appointed Chief Executive Officer. Kelly succeeds Dr. Jeff Elton, who will transition from his role as CEO to Vice Chairman of the company. Kelly comes to ConcertAI from Inovalon, a cloud-based healthcare SaaS provider, where he has served as President since 2021. During his tenure at Inovalon,ConcertAI Announce Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ -- powered by Guardant Health liquid biopsy genomic data -- and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights to accelerate clinical development in precision oncology. The agreement will fully leverage ConcertAI’s newly launched Translational360™, an integrated research-grade longitudinal clinical molecular databaConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights to accelerate clinical development in precision oncology. The agreement will fully leverage ConcertAI’s newly launched Translational360™, an integrated research-grade longitudinal clinical molecular database that taps into the CancerLinQ network of de-identified ca
Top Healthcare Software Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ConcertAI
ConcertAI, mission is to accelerate insights and improve outcomes for patients through leading real-world data, AI technologies, and scientific expertise in partnership with the leading biomedical innovators, healthcare providers, and medical societies.... Read More

